The Gastrointestinal Stromal Tumor Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Gastrointestinal Stromal Tumor Market:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-stromal-tumor-global-market-report
According to The Business Research Company’s Gastrointestinal Stromal Tumor Global Market Report 2024, The gastrointestinal stromal tumor market size has grown strongly in recent years. It will grow from $1.18 billion in 2023 to $1.28 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increased awareness and early diagnosis, emergence of targeted therapies, enhanced surgical techniques, development of personalized medicine, improvements in supportive care.The gastrointestinal stromal tumor market size is expected to see strong growth in the next few years. It will grow to $1.69 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%.
The growing incidence of stomach cancer is expected to drive the growth of the gastrointestinal stromal tumor (GIST) market in the future. Stomach cancer involves the abnormal growth and proliferation of cancerous cells in the stomach lining. While gastrointestinal stromal tumors (GISTs) can also develop in the stomach, they are distinct from stomach cancer. However, individuals with GISTs may have an elevated risk of developing additional cancers, such as small bowel adenocarcinoma, especially when multiple tumors converge into one.For example, data from Cancer Research UK indicates that the incidence of stomach cancer in the UK is projected to decrease by 12% between 2023-2025 and 2038-2040, with an average of 8 cases per 100,000 individuals annually. Despite this decline, the presence of stomach cancer continues to contribute to the growth of the gastrointestinal stromal tumor market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13248&type=smp
The gastrointestinal stromal tumor market covered in this report is segmented –
1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
2) By Indication: Stomach, Small Intestine, Others Indications
3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users
Top Major Players
Pfizer Inc.,
Hoffmann-La Roche AG,
Bayer AG,
Novartis AG,
Merck & Co. Inc.
The gastrointestinal stromal tumor market report table of contents includes:
1. Executive Summary
- Gastrointestinal Stromal Tumor Market Characteristics
- Gastrointestinal Stromal Tumor Market Trends And Strategies
- Gastrointestinal Stromal Tumor Market – Macro Economic Scenario
- Global Gastrointestinal Stromal Tumor Market Size and Growth
- Gastrointestinal Stromal Tumor Market Segmentation
- Gastrointestinal Stromal Tumor Market Regional And Country Analysis
………….
- Key Mergers And Acquisitions In The Gastrointestinal Stromal Tumor Market
- Gastrointestinal Stromal Tumor Market Future Outlook and Potential Analysis
- Appendix
List Of Tables :
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
……………
Table 74: Pfizer Inc. Financial Performance
Table 75: F. Hoffmann-La Roche AG Financial Performance
Table 76: Bayer AG Financial Performance
Table 77: Novartis AG Financial Performance
Table 78: Merck & Co. Inc. Financial Performance
Read Related Reports :
https://topprnews.com/walking-aids-market-statistics/
https://goodprnews.com/etching-machine-market-size/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
